Experience

Davis Polk advised Murphy USA Inc. in connection with an SEC-registered offering of $300 million aggregate principal amount of 5.625% senior notes due 2027. The notes were issued by Murphy…

Davis Polk advised the underwriters in connection with a secondary offering of 7,500,000 shares of Class A common stock of Evolent Health, Inc. by certain of Evolent’s existing stockholders…

Davis Polk advised Heineken N.V. on its offering of $1.1 billion aggregate principal amount of its 3.50% senior notes due 2028 and $650 million aggregate principal amount of its 4.35%…

Davis Polk advised the underwriter in connection with an SEC-registered secondary offering of 1,800,000 shares of Veritiv Corporation’s common stock by UWW Holdings, LLC at a price to the…

Davis Polk advised the representative of the underwriters in connection with an SEC-registered offering of 13,500,000 shares of common stock of Cloud Peak Energy Inc. The total proceeds of…

Davis Polk advised the lead book-running manager and representative of the underwriters in connection with its $101.9 million initial public offering of common stock of Jounce Therapeutics,…

Davis Polk advised the representatives of the underwriters in connection with the SEC-registered offering of 40,000,000 shares of common stock of Callon Petroleum Company. The shares are…

Davis Polk advised the joint book-running managers in connection with the offering of 4,000,000 shares of Class A common stock of Genesee & Wyoming Inc. The net proceeds from the Class…

Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Evolent Health, Inc. of $125 million aggregate principal amount of its 2.00% senior convertible notes…

Davis Polk advised the representative of the several underwriters in connection with an SEC-registered secondary offering of 1,568,000 shares of Veritiv Corporation’s common stock by UWW…